Cargando…

Is There a Role for Exercise When Treating Patients with Cancer with Immune Checkpoint Inhibitors? A Scoping Review

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) are drugs which treat cancer by manipulating the immune system. Exercise also influences the immune system and helps to reduce symptoms in people with cancer, particularly fatigue. However, the effect of combining exercise with ICIs has not been we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Handford, Jasmine, Chen, Miaoqi, Rai, Ridesh, Moss, Charlotte L., Enting, Deborah, Peat, Nicola, Karagiannis, Sophia N., Van Hemelrijck, Mieke, Russell, Beth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599872/ https://www.ncbi.nlm.nih.gov/pubmed/36291823 http://dx.doi.org/10.3390/cancers14205039

Ejemplares similares

Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping review
por: Chen, Miaoqi, et al.
Publicado: (2021)

Scoping review protocol: is there a role for physical activity interventions in the treatment pathway of bladder cancer?
por: Mehrotra, Sneha, et al.
Publicado: (2019)

Cancer staff in an NHS cancer center: infections, vaccination, stress and well-being support during the COVID-19 pandemic
por: Hadi, Hajer, et al.
Publicado: (2022)

COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
por: Russell, Beth, et al.
Publicado: (2020)

The incidence and prevalence of upper tract urothelial carcinoma: a systematic review
por: Soualhi, Ahmed, et al.
Publicado: (2021)

COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience
por: So, Alfred Chung Pui, et al.
Publicado: (2021)

Is there a role for physical activity interventions in the treatment pathway of bladder cancer? A scoping review of the literature
por: Bessa, Agustina, et al.
Publicado: (2021)

Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
por: Russell, Beth, et al.
Publicado: (2020)

Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19
por: So, Alfred Chung Pui, et al.
Publicado: (2022)

Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence
por: Russell, Beth, et al.
Publicado: (2020)

The need for supportive mental wellbeing interventions in bladder cancer patients: A systematic review of the literature
por: Bessa, Agustina, et al.
Publicado: (2021)

Designing a Pragmatic Intervention to Help Improve the Bladder Cancer Patient Experience
por: Bessa, Agustina, et al.
Publicado: (2021)

Survival Outcomes in Invasive Lobular Carcinoma Compared to Oestrogen Receptor-Positive Invasive Ductal Carcinoma
por: Timbres, Jasmine, et al.
Publicado: (2021)

Serum IgG Is Associated With Risk of Melanoma in the Swedish AMORIS Study
por: Kessler, Anna, et al.
Publicado: (2019)

One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer
por: Moss, Charlotte, et al.
Publicado: (2020)

Scoping review protocol: bladder cancer in Nigeria: what are the gaps in clinical care and research?
por: Kibaru, Joyce, et al.
Publicado: (2021)

Effect of a brief physical activity-based presentation by a former patient for men treated with radical prostatectomy for prostate cancer: a mixed methods pilot study
por: Fox, Louis, et al.
Publicado: (2020)

Antibodies as biomarkers for cancer risk: a systematic review
por: Monroy-Iglesias, Maria J, et al.
Publicado: (2022)

Graham Roberts Study protocol: first ‘trials within cohort study’ for bladder cancer
por: Wylie, Harriet, et al.
Publicado: (2019)

The impact of hospital attendance on COVID-19 infection in cancer patients: an assessment of data from Guy's Cancer
por: Tremble, Kathryn, et al.
Publicado: (2022)

Cohort profile: King’s Health Partners bladder cancer biobank
por: Kotecha, Pinky, et al.
Publicado: (2020)

A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0
por: Russell, Beth, et al.
Publicado: (2018)

Real World Data Studies of Antineoplastic Drugs: How Can They Be Improved to Steer Everyday Use in the Clinic?
por: George, Gincy, et al.
Publicado: (2023)

Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study
por: Santaolalla, Aida, et al.
Publicado: (2021)

Impact of age on the toxicity of immune checkpoint inhibition
por: Samani, Amit, et al.
Publicado: (2020)

Scoping review: bladder cancer in Nigeria – what are the gaps in clinical care and research?
por: Iya, Abdulkarim Muhammad, et al.
Publicado: (2022)

A mediation analysis to explain socio‐economic differences in bladder cancer survival
por: Russell, Beth, et al.
Publicado: (2020)

An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice
por: Moss, Miss Charlotte L., et al.
Publicado: (2021)

Scientific writing: easy when you know how
por: Peat, Jennifer
Publicado: (2002)

Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction – A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic
por: Santaolalla, Aida, et al.
Publicado: (2020)

Checkpoint and PARP inhibitors, for whom and when
por: Lee, Jung-Min, et al.
Publicado: (2017)

Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators
por: Russell, Beth, et al.
Publicado: (2021)

Editorial: The effects of COVID-19 on cancer research methods & strategies
por: Fox, Louis, et al.
Publicado: (2022)

Research engagement among black men with prostate cancer
por: Toms, Charlotte, et al.
Publicado: (2016)

Comment on “Effects of Scheduled Exercise on Cancer-Related Fatigue in Women with Early Breast Cancer”
por: Veal, Isla, et al.
Publicado: (2015)

Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival
por: Wulaningsih, Wahyu, et al.
Publicado: (2016)

Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave
por: Russell, Beth, et al.
Publicado: (2022)

Serum Total Bilirubin and Risk of Cancer: A Swedish Cohort Study and Meta-Analysis
por: Monroy-Iglesias, Maria J., et al.
Publicado: (2021)

Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study
por: Sollie, Sam, et al.
Publicado: (2019)

Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study
por: Sollie, Sam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_11dqfth4ej3i1ah119eva15pdr